ESR1 and ovarian carcinoma: These results indicate that estrogen can modulate lncRNA expression in ERα+ ovarian cancer cells, and that certain lncRNAs are correlated with advanced cancer progression and are a suggestive prognostic indicator in ERα+ ovarian cancer patients.